SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharmaceuticals gets nod to raise upto Rs 12,500 crore through NCDs

06 Jan 2026 Evaluate

Torrent Pharmaceuticals has received approval from Securities Transfer and Stakeholders Relationship Committee (STSRC) for issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating upto Rs 12,500 crore in one or more tranches on private placement basis.

Securities Transfer and Stakeholders Relationship Committee (STSRC) has at its meeting held on January 05, 2026 has approved the same. 

Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

4172.50 -15.65 (-0.37%)
21-Apr-2026 09:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.20
Dr. Reddys Lab 1227.10
Cipla 1229.10
Zydus Lifesciences 932.05
Lupin 2333.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×